Skip to main content

Diabetic Retinopathy and Its Management

  • Chapter
Geriatric Ophthalmology
  • 700 Accesses

Abstract

A 70-year-old man notes progressive problems with reading the newspaper and seeing signs while driving over the past year. His most recent examination with a comprehensive ophthalmologist was approximately 3 years ago when he was told he had some evidence of “diabetes” in his eyes. He also has a past medical history of diabetes for which he is taking an oral hypoglycemic agent, and a history of hypertension for which he is taking two medications, but he cannot recall what the medications are, and did not bring them to his examination. He is not aware what his hemoglobin A1C level is, but his reply to this question also was that he might have “a little anemia.”

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. The Eye Disease Prevalence Research Group: The Prevalence of Diabetic Retinopathy Among Adults in the United States. Arch Ophthalmol. 2004;122:552–563.

    Article  Google Scholar 

  2. Mokdad AH, Ford ES, Bowman BA, et al.Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76–79.

    Article  PubMed  Google Scholar 

  3. Do DV, Nguyen QD, Bressler NM, et al. Hemoglobin A1C awareness among patients receiving eye care at a tertiary ophthalmic center. Am J Ophthalmol. 2006;141:951–953.

    Article  PubMed  Google Scholar 

  4. Bressler SB, Bressler NM. Commentary: Retinopathy in patients with type I diabetes four years after intensive therapy. Arch Ophthalmol. 2000;118:984–985.

    PubMed  CAS  Google Scholar 

  5. Early Treatment Diabetic Retinopathy Study (ETDRS): Photocoagulation for diabetic macular edema. Early treatment diabetic retinopathy study report number 1. Arch Ophthalmol. 1985;103:1796–806.

    Article  Google Scholar 

  6. Diabetic Retinopathy Clinical Research Network: A randomized trial comparing intravitreal triamcinolone and focal/grid photocoagulation for diabetic macular edema. Ophthalmology. 2008;115:1447–1459.e10.

    Google Scholar 

  7. Nguyen QD, Shah SM, Hafiz G, et al. Intravenous bevacizumab causes regression of choroidal neovascularization secondary to diseases other than age-related macular degeneration. Am J Ophthalmol. 2008 Feb;145(2):257–266.

    Article  PubMed  CAS  Google Scholar 

  8. American Academy of Ophthalmology. Preferred Practice Pattern: Diabetic Retinopathy. San Francisco, CA: American Academy of Ophthalmology; 1998.

    Google Scholar 

  9. The Diabetic Retinopathy Vitrectomy Study Research Group: Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy: Four-year results of a randomized trial. Diabetic retinopathy vitrectomy study report number 5. Arch Ophthalmol. 1990;108:958–964.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Bressler, N.M. (2009). Diabetic Retinopathy and Its Management. In: Lee, A.G., Beaver, H. (eds) Geriatric Ophthalmology. Springer, New York, NY. https://doi.org/10.1007/b137372_5

Download citation

  • DOI: https://doi.org/10.1007/b137372_5

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-0009-8

  • Online ISBN: 978-1-4419-0014-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics